Cargando…

Rupatadine Oral Solution Titration by Body Weight in Paediatric Patients Suffering from Allergic Rhinitis: A Population Pharmacokinetic Study

BACKGROUND: Allergic rhinitis (AR) and chronic urticaria, both are treated in children with doses of second generation of antihistamines that have been mostly based on extrapolation of data obtained in adults. The objectives of this work were to develop a model to explain the pharmacokinetics (PK) o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santamaria, Eva, Izquierdo, Iñaki, Valle, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197573/ https://www.ncbi.nlm.nih.gov/pubmed/34135645 http://dx.doi.org/10.2147/CPAA.S312911

Ejemplares similares

Rupatadine oral solution for 2–5-year-old children with allergic rhinitis: a safety, open-label, prospective study
por: Santamaría, Eva, et al.
Publicado: (2018)

Population pharmacokinetic modelling of rupatadine solution in 6–11 year olds and optimisation of the experimental design in younger children
por: Santamaría, Eva, et al.
Publicado: (2017)

PD39 - Application of population pharmacokinetic modeling and simulation in the design of the optimal dose regime of rupatadine in children 2-5 year old children
por: Valle, Marta, et al.
Publicado: (2014)

Clinically relevant effect of rupatadine 20 mg and 10 mg in seasonal allergic rhinitis: a pooled responder analysis
por: Mullol, Joaquim, et al.
Publicado: (2019)

Rupatadine oral solution improves rhino-conjunctive symptoms control in children with 6-11 years weighing ≥25 kg with persistent allergic rhinitis
por: Izquierdo, Iñaki, et al.
Publicado: (2013)

Higher efficacy of rupatadine 20 mg and 10 mg versus placebo in patients with perennial allergic rhinitis: a pooled responder analysis
por: Valero, Antonio, et al.
Publicado: (2020)

Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial
por: Marmouz, Farid, et al.
Publicado: (2011)

Pharmacokinetics, Safety and Cognitive Function Profile of Rupatadine 10, 20 and 40 mg in Healthy Japanese Subjects: A Randomised Placebo-Controlled Trial
por: Täubel, Jörg, et al.
Publicado: (2016)

Efficacy and Safety of Rupatadine Fumarate Combined with Acupoint Application in Allergic Rhinitis Complicated with Diabetes
por: Liu, Yu, et al.
Publicado: (2022)

FUTURA STUDY-Evaluation of efficacy and safety of rupatadine fumarate in the treatment of persistent allergic rhinitis
por: de Godoy Mion, Olavo, et al.
Publicado: (2015)

Olopatadine hydrochloride and rupatadine fumarate in seasonal allergic rhinitis: A comparative study of efficacy and safety
por: Maiti, Rituparna, et al.
Publicado: (2011)

O10 - Rupatadine is effective and safe in the treatment of Chronic Spontaneous Urticaria (CSU) in pediatric patients (2-11 years old)
por: Potter, Paul, et al.
Publicado: (2014)

Rupatadine
por: Kaur, Manpreet, et al.
Publicado: (2013)

Long-term safety and efficacy of rupatadine in Japanese patients with perennial allergic rhinitis: a 52-week open-label clinical trial
por: Okubo, Kimihiro, et al.
Publicado: (2019)

Comparison of efficacy, safety, and cost-effectiveness of rupatadine and olopatadine in patients of allergic rhinitis: A prospective, randomized, double-blind, parallel group study
por: Dakhale, Ganesh, et al.
Publicado: (2016)

Evaluation of nasal symptoms induced by platelet activating factor, after nasal challenge in both healthy and allergic rhinitis subjects pretreated with rupatadine, levocetirizine or placebo in a cross-over study design
por: Muñoz-Cano, Rosa, et al.
Publicado: (2013)

Modulation of Allergic Inflammation in the Nasal Mucosa of Allergic Rhinitis Sufferers With Topical Pharmaceutical Agents
por: Watts, Annabelle M., et al.
Publicado: (2019)

Rupatadine to prevent local allergic reactions to sublingual allergy immunotherapy: a case series
por: Ellis, Anne K., et al.
Publicado: (2021)

A direct comparison of efficacy between desloratadine and rupatadine in seasonal allergic rhinoconjunctivitis: a randomized, double-blind, placebo-controlled study
por: Lukat, KF, et al.
Publicado: (2013)

Rupatadine in Established Treatment Schemes Improves Chronic Spontaneous Urticaria Symptoms and Patients’ Quality of Life: a Prospective, Non-interventional Trial
por: Metz, Martin, et al.
Publicado: (2015)

Pharmacokinetics and Concentration‐Response of Dupilumab in Patients With Seasonal Allergic Rhinitis
por: Kamal, Mohamed A., et al.
Publicado: (2022)

Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial [Corrigendum]
Publicado: (2015)

Dual systemic allergic rhinitis and local allergic rhinitis
por: Blanca, Miguel, et al.
Publicado: (2015)

Allergic rhinitis
por: Small, Peter, et al.
Publicado: (2011)

Allergic rhinitis
por: Small, Peter, et al.
Publicado: (2018)

207 Approach of Paediatric Allergists to Allergen Immunotherapy in Severe Persistent Allergic Rhinitis
por: Fiocchi, Alessandro, et al.
Publicado: (2012)

Montelukast in paediatric asthma and allergic rhinitis: a systematic review and meta-analysis
por: Mayoral, Karina, et al.
Publicado: (2023)

Allergen Challenge Chamber: an innovative solution in allergic rhinitis diagnosis
por: Krzych-Fałta, Edyta, et al.
Publicado: (2015)

Allergic Sensitization, Rhinitis and Tobacco Smoke Exposure in US Adults
por: Shargorodsky, Josef, et al.
Publicado: (2015)

Management of Rhinitis: Allergic and Non-Allergic
por: Tran, Nguyen P, et al.
Publicado: (2011)

Management of allergic rhinitis
por: Solelhac, Geoffroy, et al.
Publicado: (2014)

Acute allergic rhinitis
por: Green, Robin J., et al.
Publicado: (2020)

Probiotics in allergic rhinitis
por: Nogueira, Janaina Cândida Rodrigues, et al.
Publicado: (2015)

Local allergic rhinitis()
por: Mello Junior, João Ferreira de
Publicado: (2016)

Microbial characterization of the nasal cavity in patients with allergic rhinitis and non-allergic rhinitis
por: Che, Yanlu, et al.
Publicado: (2023)

A Model for the Determination of Pollen Count Using Google Search Queries for Patients Suffering from Allergic Rhinitis
por: König, Volker, et al.
Publicado: (2014)

Nasal IgE in subjects with allergic and non-allergic rhinitis
por: Eckrich, Jonas, et al.
Publicado: (2020)

Montelukast in the treatment of perennial allergic rhinitis in paediatric Japanese patients; an open-label clinical trial
por: Okubo, Kimihiro, et al.
Publicado: (2016)

Rupatadine Treatment Is Associated with Atherosclerosis Worsening and Altered T Lymphocyte Recruitment
por: Busnelli, Marco, et al.
Publicado: (2022)

Self-assessment of Allergic Rhinitis and Asthma (SACRA) Questionnaire-based Allergic Rhinitis Treatment Improves Asthma Control in Asthmatic Patients with Allergic Rhinitis
por: Yasuo, Masanori, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dgi84n7aglb0nf1n3u92cgspq9